 CARLSBAD, Calif., Aug. 24, 2021 GLOBE NEWSWIRE -- Palisade Bio, Inc. Nasdaq: PALI Palisade or the Company, a late-stage biopharma company advancing therapies for acute and chronic gastrointestinal GI complications, today provides a business update and releases its financial results for the second quarter ending June 30, 2021. 